CYCLOSPORINE AND ISLET MASS - IMPLICATIONS FOR ISLET TRANSPLANTATION

被引:6
|
作者
METRAKOS, P [1 ]
HORNBY, L [1 ]
ROSENBERG, L [1 ]
机构
[1] MCGILL UNIV,MONTREAL GEN HOSP,DEPT SURG,1650 CEDAR AVE,L9-424,MONTREAL H3A 1A1,QUEBEC,CANADA
关键词
D O I
10.1006/jsre.1993.1060
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cyclosporine (CsA) is an inhibitor of ornithine decarboxylase (ODC), a key enzymatic step in cell proliferation. The purpose of this study was to determine the effect of CsA on islet cell mass. Partial obstruction (PDO) of the hamster pancreas is an established model of islet cell differentiation and proliferation in which regeneration is mediated by the induction of trophic activity (TA) that can be extracted from the pancreas. In Part 1 of these studies, hamsters were randomized to (i) Control (n = 5); (ii) PDO alone (n = 5); (iii) PDO + CsA (20 mg/kg ip daily) (n = 5); (iv) CsA alone (n = 5). On Day 21, 1 hr prior to sacrifice, animals received tritiated thymidine, 2 μCi/g body wt ip. Pancreata were excised for analysis of islet cell mass (No. islets/mm2) by morphometry and of cell proliferation (islet cell labeling index) by autoradiography. In Part 2 of these studies, hamsters were randomized to receive CsA (n = 34), as in Part 1, or saline (n = 30). After 7 days, animals received 1 ml of TA ip and were sacrificed after 0, 6, 8, and 10 hr. The pancreata were excised and determinations made of organ weight, DNA content, and ODC bioactivity (pmole/CO2/hr/mg DNA). Data (mean ± SEM) were analyzed by ANOVA. In Part 1, the number of islets/mm2 in the PDO group was increased two-fold compared to control animals, those receiving CsA, and those undergoing PDO with CsA (2.4 ± 0.1 vs 1.1 ± 0.0, 1.4 ± 0.2, 1.2 ± 0.1, P < 0.01). An increase of similar magnitude was also noted in the islet cell labeling index (0.56 ± 0.06 vs 0.22 ± 0.07, 0.17 ± 0.05, 0.24 ± 0.01, P < 0.01). In Part 2 of the study, TA induced a significant eightfold increase in ODC bioactivity which was completely abrogated by prior treatment with CsA. We conclude that, in this model, CsA blocks islet cell proliferation and differentiation by inhibition of TA-stimulated ODC activity. If ongoing islet cell proliferation is necessary for maintenance of islet allograft survival, then the use of CsA in islet transplantation may need to be reassessed. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 50 条
  • [41] Xenogeneic islet transplantation
    Hering, Bernhard J.
    XENOTRANSPLANTATION, 2007, 14 (05) : 443 - 443
  • [42] Pancreatic islet transplantation
    Salmela, K
    ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 1997, 86 (02) : 149 - 151
  • [43] PANCREAS AND ISLET TRANSPLANTATION
    KENDALL, DM
    ROBERTSON, RP
    ENDOCRINOLOGIST, 1995, 5 (01): : 28 - 35
  • [44] Pancreas and islet transplantation
    Schenker, P.
    Viebahn, R.
    CHIRURG, 2009, 80 (05): : 422 - +
  • [45] Pancreatic islet transplantation
    Noguchi, Hirofumi
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 1 (01): : 16 - 20
  • [46] History of islet transplantation
    Benigno J. Digon
    Current Diabetes Reports, 2009, 9 : 312 - 316
  • [47] Update on Islet Transplantation
    McCall, Michael
    Shapiro, A. M. James
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (07):
  • [48] ISLET TRANSPLANTATION WITH IMMUNOISOLATION
    LANZA, RP
    SULLIVAN, SJ
    CHICK, WL
    DIABETES, 1992, 41 (12) : 1503 - 1510
  • [49] Islet transplantation in Korea
    Lee, Joonyub
    Yoon, Kun-Ho
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (09) : 1165 - 1170
  • [50] TRANSPLANTATION OF ISLET CELLS
    TOLEDOPEREYRA, LH
    GORDON, DA
    MACKENZIE, GH
    SURGERY GYNECOLOGY & OBSTETRICS, 1984, 158 (01): : 49 - 56